Asthma Drugs Market Revenue 2024 to 2034
Asthma Drugs Market Revenue 2024 to 2034
The asthma drugs market will expand from USD 25.17 Bn in 2024 to USD 41.04 Bn by 2034, at a 5.01% CAGR, fueled by rising asthma prevalence, biologics adoption, and growing demand for advanced inhalation therapies.
Report ID: 10571
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 25.17 Bn
Forecast Year,
USD 41.04 Bn
CAGR, 2025 -
5.01%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Asthma Drugs Market Size Analysis
Asthma Drugs Market Size By Medication 2024 to 2034 (USD )
| Medication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term Control | 14.60 | 15.35 | 16.13 | 16.96 | 17.82 | 18.74 | 19.70 | 20.70 | 21.76 | 22.88 | 24.05 |
| Quick Relief | 10.57 | 11.09 | 11.62 | 12.19 | 12.78 | 13.40 | 14.05 | 14.74 | 15.45 | 16.20 | 16.99 |
Asthma Drugs Market Size By Mode of Administration 2024 to 2034 (USD )
| Mode of Administration | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhalers | 18.12 | 18.99 | 19.90 | 20.85 | 21.85 | 22.90 | 23.99 | 25.14 | 26.35 | 27.61 | 28.93 |
| Nebulizers | 7.05 | 7.44 | 7.86 | 8.29 | 8.76 | 9.24 | 9.76 | 10.30 | 10.87 | 11.47 | 12.11 |
Asthma Drugs Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 11.07 | 11.65 | 12.26 | 12.91 | 13.58 | 14.29 | 15.04 | 15.83 | 16.66 | 17.53 | 18.44 |
| Homecare | 10.57 | 11.08 | 11.61 | 12.16 | 12.74 | 13.35 | 13.99 | 14.66 | 15.36 | 16.10 | 16.86 |
| Others | 3.52 | 3.70 | 3.88 | 4.08 | 4.28 | 4.49 | 4.72 | 4.95 | 5.20 | 5.46 | 5.73 |
Asthma Drugs Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 9.06 | 9.46 | 9.88 | 10.31 | 10.77 | 11.24 | 11.74 | 12.25 | 12.79 | 13.35 | 13.93 |
| Europe | 7.05 | 7.42 | 7.80 | 8.21 | 8.64 | 9.09 | 9.56 | 10.06 | 10.58 | 11.14 | 11.72 |
| Asia Pacific | 7.30 | 7.69 | 8.11 | 8.55 | 9.01 | 9.49 | 10.01 | 10.55 | 11.11 | 11.71 | 12.34 |
| Latin America | 1.01 | 1.11 | 1.23 | 1.35 | 1.49 | 1.63 | 1.79 | 1.95 | 2.13 | 2.32 | 2.52 |
| Middle East & Africa | 0.76 | 0.75 | 0.74 | 0.72 | 0.71 | 0.69 | 0.66 | 0.63 | 0.60 | 0.56 | 0.52 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
